Navigation Links
Olympic Champion and Health and Fitness Advocate Dara Torres Partners with Vestiage

Newport Beach, California (PRWEB) July 25, 2013

Vestiage Inc., (stock symbol "VEST") announced today that Olympic icon, mom, and health and fitness advocate Dara Torres, age 46, has signed an exclusive endorsement agreement with the Company. Torres is the first and only Olympic swimmer in history to participate in 5 Olympic Games. When she was 41 she became the first woman in history to swim in the Olympics past the age of 40. During her athletic career, she has won 4 of each gold, silver and bronze medals. At the age of 40 in 2007, 15 months after giving birth to her daughter Tessa, she won a gold medal at the US Nationals. Three days later she broke her own record in the 50 meter freestyle, 25 years after she first set the American record at age 15. Vestiage is a company focused on peak performance at every stage of life, anti-aging science-based products, and helping people live high quality lives and age beautifully.

Vestiage CEO Scott Kimball stated, "There is no human being on the planet that better depicts the qualities, philosophies and goals we have at Vestiage than Dara Torres. I think all of us at some level are curious as to how certain people are able to age without limitations, live beautifully as they age, perform well physically and mentally as they age, and maintain a high quality of life as they age. Dara is living proof that you can perform better with age and remain beautiful as you age. At Vestiage, this is our passion and our quest, to deliver the findings from science and research to consumers in the form of science-based products that indeed help people live well and perform well both physically and mentally as they age. Dara joined us because of her shared passion for these things and our philosophical stand and integrity in this business. We are so grateful for her involvement. She will join our Board of Advisors and assist with the promotion of our Company and our premium and prestige brands. She will have input into the overall direction of the Company, our product research and development activities, and our endorsements with other athletes and personalities".

"At the age of 46, I am now a middle aged mom and ex-athlete who continues to stay fit and has a passion to help others do the same," said Dara Torres. "Vestiage was the first company I felt had great products, a strong strategic plan and wanted input on what 40+ women and men wanted from the products they take daily. The opportunity to work on educating my peer group on how the Vestiage vision can help their quality of life is now my mission!" said Torres, Olympic Gold Medalist, mom, and health & fitness advocate.

About Vestiage
Vestiage (stock symbol "VEST") is a publicly traded anti-aging lifestyle company offering premium branded, science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the mission of extending the quality of human life using human stem cell, marine/ocean, and cutting edge botanically based science and patented ingredients to produce pure, highly potent and effective products. Vestiage creates and distributes cosmeceuticals such as Reluma ( and multifunctional nutraceuticals through Monterey Bay Nutraceuticals ( Vestiage brands address the top “in demand” anti-aging consumer concerns. Vestiage research is focused on extending the quality of life and human performance science that covers both the cognitive and physical realms. As clinical results validate discoveries, Vestiage intends to apply new potential ingredients or ingredient formulations and combinations to its anti-aging products across its brands. To learn more, visit the Company website,

This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forwardlooking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control. Copies of our reports are available upon request from our investor relations department or may be obtained at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Space Dive Filming, 3D Olympics Coverage Among Highlights at IS&T/SPIE Electronic Imaging Next Month
2. NeuroTracker boosts concentration for Olympic shooter
3. GenoSpace Founder and CEO Receives "Champions of Change" Award from White House
4. North Carolina A&T State University Crowned Champion in $100,000 ACC Clean Energy Challenge
5. Champions Oncology Reports Financial Results for the Quarter Ended October 31, 2012
6. CSL Behring Partners with Pro Supercross Racer Carl Schlacht to Encourage Those with Primary Immunodeficiency to be a "ChamPIon"
7. Amarantus Appoints Super Bowl Champion Toi Cook to Board of Advisors to Advance TBI Program
8. Champions Oncology Reports Financial Results for the Year Ended April 30, 2012
9. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
10. First 3D Complex Cataract Surgery Performed in Canada at Trillium Health Partners
11. Cardno Expands to Include a New Business Line Focused on Health Sciences
Post Your Comments:
(Date:11/27/2015)... United Kingdom , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt ... biopharmaceutical company, announced today that it has closed the ... (CMDS) business to Guerbet (GBT- NYSE Euronext) in a ... operations encompassed four manufacturing facilities and a total of ... 75 in the St. Louis ...
(Date:11/26/2015)... 2015 ... Research Laboratories, a leading independent and ... has formed a strategic partnership with ... Health for joint work on clinical ... ) , --> ,     ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... a biotechnology company developing bioengineered organ implants for life-threatening ... will present at the LD Micro "Main Event" investor ... PT. The presentation will be webcast live and posted ... also be available at the conference for one-on-one meetings ...
Breaking Biology Technology:
(Date:10/29/2015)... JOLLA, Calif. , Oct. 29, 2015  The ... a new report titled, "DNA Synthesis and Biosecurity: Lessons ... well the Department of Health and Human Services guidance ... issued in 2010. --> ... but it also has the potential to pose unique ...
(Date:10/29/2015)... 29, 2015 Today, LifeBEAM , ... with 2XU, a global leader in technical performance ... hat with advanced bio-sensing technology. The hat will ... monitor key biometrics to improve overall training performance. ... two companies will bring together the most advanced technology, ...
(Date:10/26/2015)... LAS VEGAS , Oct. 26, 2015 ... an innovator in modern authentication and a founding member ... launch of its latest version of the Nok Nok™ ... to use standards-based authentication that supports existing and emerging ... Suite is ideal for organizations deploying customer-facing applications that ...
Breaking Biology News(10 mins):